why choose us

First received: May 26, 2023

Clinical Trial: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Brief Summary: The primary purpose of this study is to assess the safety and tolerability of AB598 when taken alone, and in combination with zimberelimab and standard chemotherapy in participants with advanced malignancies.

Read more